Top

Supportive Care in Cancer

Published in:

01-02-2012 | Review Aricle

Clinical exercise interventions in prostate cancer patients—a systematic review of randomized controlled trials

Authors: Freerk T. Baumann, Eva M. Zopf, Wilhelm Bloch

Published in: Supportive Care in Cancer | Issue 2/2012

Abstract

Introduction

Urinary incontinence, erectile dysfunction, fatigue as well as fears and depression rank among the most common complaints in patients with prostate cancer, resulting in a reduced participation in daily life and social isolation. Consequently, the quality of life of prostate cancer patients is strongly affected in a negative way. Numerous studies focusing on physical exercise interventions in prostate cancers patients demonstrate positive physiological and psychological effects. Our objective was to evaluate the evidence of randomized controlled studies which examined exercise during medical treatment and in the aftercare of a prostate cancer disease.

Methods

Twenty-five randomized controlled trials regarding physical activities in patients with prostate cancer were obtained by systematic literature research (Medpilot). Twenty-one studies examined clinical exercise interventions during the phase of medical treatment (irradiation, pre- and/or post-op, androgen deprivation therapy) and four studies during the aftercare. In order to evaluate the evidence of the included studies, the evaluation system of the Oxford Centre for Evidence-Based Medicine was used. Within this systematic review, we differentiated between “supervised clinical exercise” and “non-supervised clinical exercise.”

Results and discussion

Current data suggest that incontinence, fitness, fatigue, body constitution, and also quality of life can be improved by clinical exercise in patients during and after prostate cancer. Studies were mostly ranked evidence level “2b.” Only four studies, all conducted during medical treatment, reached the level “1b.” It seems to be that “supervised exercise” is more effective than “non-supervised exercise.” For future research, further randomized controlled trials with high methodological quality need to be conducted in order to establish evidence-based recommendations particularly for prostate cancer patients.

Zank D (2006) Prostatakarzinom. In: Hostetter A (ed) Prostatakarzinom- Fortschritte in Diagnostik und Therapie. Urban & Vogel, München, pp 11–13

Robert Koch Institute and Association of Population-based Cancer Registries in Germany (ed.). (2010) Cancer in Germany 2005/2006. Incidence and Trends. Seventh edition. Robert-Koch-Institut, Berlin

Leach GE (1995) Post-prostatectomy incontinence: the importance of bladder dysfunction. J Urol 153(3):1038PubMedCrossRef

Frydenberg M, Stricker PD, Kaye KW (1997) Prostate cancer diagnosis and management. Lancet 349:1681–1687PubMedCrossRef

Kirschner-Hermanns R, Jakse G (2002) Quality of life following radical prostatectomy. Crit Rev Oncol Hematol 43:141–151PubMedCrossRef

Liatsikos EN, Assimakopoulos K, Stolzenburg JU (2008) Quality of life after radical prostatectomy. Urol Int 80:226–230PubMedCrossRef

Kunkel EJS, Bakker JR, Myers RE, Oyesanmi O, Gomella LG (2000) Biopsychosocial aspects of prostate cancer. Psychosomatics 41:85–94PubMedCrossRef

Smith MR, Finkelstein JS, McGovern FJ, Zietman AL, Fallon MA, Schoenfeld DA et al (2002) Changes in body composition during androgen deprivation therapy for prostate cancer. J Clin Endocrinol Metab 87(2):599–603PubMedCrossRef

Zelefsky MJ, Eid JF (1998) Elucidating the etiology of erectile dysfunction after definitive therapy for prostate cancer. Int J Radiat Oncol Biol Phys 40:129–133PubMedCrossRef

10.

Thorsen L, Courneya KS, Stevinson C, Fossa SD (2008) A systematic review of physical activity in prostate cancer survivors: outcomes, prevalence, and determinants. Support Care Cancer 16(9):987–997PubMedCrossRef

11.

Taylor LG, Canfield SE, Du XL (2009) Review of major adverse effects of androgen deprivation therapy in men with prostate cancer. Cancer 115:2388–2399PubMedCrossRef

12.

Kintzel PE, Chase SL, Schultz LM, O’Rourke T (2008) Increased risk of metabolic syndrome, diabetes mellitus, and cardiovascular disease in men receiving androgen deprivation therapy for prostate cancer. Pharmacotherapy 28(12):1511–1522PubMedCrossRef

13.

Saigal CS, Gore JL, Krupski TL, Hanley J, Schonlau M, Litwin MS (2007) Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer. Cancer 110(7):1493–1500PubMedCrossRef

14.

Humpel N, Iverson D (2005) Review and critique of the quality of exercise recommendations for cancer patients and survivors. Support Care Cancer 13:493–502PubMedCrossRef

15.

Mustian KM, Morrow GG, Carroll JK, Figueroa-Moseley CD, Jean-Pierre P, Williams GC (200) Integrative nonpharmacologic behavioral interventions for management of cancer-related fatigue. Oncologist 12(suppl1):52–67

16.

Van Weert E, Hoekstra-Weebers J, May AM, Korstjens AM, Ros I, van der Schans CP (2008) The development of an evidence-based physical self-management rehabilitation programme for cancer survivors. Patient Educ Couns 71:169–190PubMedCrossRef

17.

Viskovsky C, Dvorak C (2005) Exercise and cancer recovery. Online journal of issues in nursing 28;10(2):7

18.

Hayes S, Spence R, Galvao D, Newton R (2009) Australian Association for Exercise and Sport Science position stand: optimising cancer outcomes through exercise. J Sci Med Sport 12:428–434PubMedCrossRef

19.

Newton R, Galvao D (2008) Exercise in prevention and management of cancer. Curr Treat Options Oncol 9:135–146PubMedCrossRef

20.

Holmes MD, Chen WY, Feskanich D, Kroenke CH, Colditz GA (2005) Physical activity and survival after breast cancer diagnosis. JAMA 293:2479–2486PubMedCrossRef

21.

Meyerhardt JA, Heseltine D, Niedzwiecki D, Hollis D, Saltz LB, Mayer RJ et al (2006) Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803. J Clin Oncol 24(22):3535–3541PubMedCrossRef

22.

Kenfield SA, Stampfer MJ, Giovannucci E, Chan JM (2011) Physical activity and survival after prostate cancer diagnosis in the health professionals follow-up study. J Clin Oncol 29(6):726–732PubMedCrossRef

23.

Schmitz KH, Courneya KS, Matthews C, Demark-Wahnefried W, Galvão DA, Pinto BM, Irwin ML, Wolin KY, Segal RJ, Lucia A, Schneider CM, von Gruenigen VE, Schwartz AL (2010) American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc 42(7):1409–1426PubMedCrossRef

24.

MacDermid J, Law M (2008) Evaluating the evidence. In: Law MC, MacDermind J (eds) Evidence-based rehabilitation: a guide to practice. SLACK Incorporated, Thorofare, p 122f

25.

Atkins D, Eccles M, Flottorp S, Guyatt GH, Henry D, Hill S et al. (2004) Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches The GRADE Working Group. BMC Health Services Research 4(1):38

26.

Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck-Ytter Y, Schünemann HJ, Alderson P, Alonso-Coello P, Andrews J, Atkins D, Bastian H, de Beer H, Brozek J, Cluzeau F, Craig J, Djulbegovic B, Falck-Ytter Y, Fervers B, Flottorp S, Glasziou P, Guyatt GH, Haugh M, Harbour R, Helfand M, Hill S, Jaeschke R, Jones K, Kunnamo I, Kunz R, Liberati A, Marzo M, Mason MJ, Norris S, Oxman AD, Robinson V, Schünemann HJ, Tan TT, Tovey D, Tugwell P, Tuut M, Varonen H, Vist GE, Wittington C, Williams J, Woodcock J (2008) What is "quality of evidence" and why is it important to clinicians? BMJ 336(7651):995–998PubMedCrossRef

27.

Segal RJ, Reid RD, Courneya RJ, Sigal GP, Kenny DG, Prud-Homme DG et al (2009) Randomized controlled trial of resistance or aerobic exercise in men receiving radiation for prostate cancer. J Clin Oncol 27(3):344–351PubMedCrossRef

28.

Monga U, Garber SL, Thornby J, Vallbona C, Kerrigan AJ, Monga TN et al (2007) Exercise prevents fatigue and improves quality of life in prostate cancer patients undergoing radiotherapy. Arch Phys Med Rehabil 88(11):1416–1422PubMedCrossRef

29.

Windsor PM, Nicol KF, Potter J (2004) A randomized, controlled trial of aerobic exercise for treatment-related fatigue in men receiving radical external beam radiotherapy for localized prostate carcinoma. Cancer 101(3):550–557PubMedCrossRef

30.

Kapur G, Windsor PM, McCowan C (2010) The effect of aerobic exercise on treatment-related acute toxicity in men receiving radical external beam radiotherapy for localized prostate cancer. Eur J Cancer Care 19:643–647CrossRef

31.

Galvao DA, Taaffe DR, Spry N, Joseph D, Newton RU (2010) Combined resistance and aerobic exercise program reverses muscle loss in men undergoing androgen suppression therapy for prostate cancer without bone metastases: a randomized controlled trial. J Clin Oncol 28(2):340–347PubMedCrossRef

32.

Culos-Reed SN, Robinson JW, Lau H, Stephenson L, Keats M, Norris S, Kline G, Faris P (2010) Physical activity for men receiving androgen deprivation therapy for prostate cancer: benefits from a 16-week intervention. Support Care Cancer 18:591–599PubMedCrossRef

33.

Segal RJ, Reid RD, Courneya KS, Malone SC, Parliament MB, Scott CG et al (2003) Resistance exercise in men receiving androgen deprivation therapy for prostate cancer. J Clin Oncol 21(9):1653–1659PubMedCrossRef

34.

Overgard M, Angelsen A, Lydersen S, Mørkved S (2008) Does physiotherapist-guided pelvic floor muscle training reduce urinary incontinence after radical prostatectomy? A randomized controlled trial. Eur Urol 54(2):438–448PubMedCrossRef

35.

Manassero F, Traversi C, Ales V, Pistolesi D, Panicucci E, Valent F et al (2007) Contribution of early intensive prolonged pelvic floor exercises on urinary continence recovery after bladder neck-sparing radical prostatectomy: results of a prospective controlled randomized trial. Neurourol Urodyn 26(7):985–989PubMedCrossRef

36.

Burgio KL, Goode PS, Urban DA, Umlauf MG, Locher JL, Bueschen A et al (2006) Preoperative biofeedback assisted behavioral training to decrease post-prostatectomy incontinence: a randomized, controlled trial. J Urol 175(1):196–201PubMedCrossRef

37.

Lilli P, Mercuriali M, Fiori M, Hanitzsch H, Gunelli R, Bercovich E (2006) Impact of preoperative biofeedback on incontinence in cancer patients undergoing radical prostatectomy. Arch Ital Urol Androl 78(3):92–96PubMed

38.

Pannek J, König JE (2005) Clinical usefulness of pelvic floor reeducation for men undergoing radical prostatectomy. Urol Int 74(1):38–43PubMedCrossRef

39.

Filocamo MT, Li Marzi V, Del Popolo G, Cecconi F, Marzocco M, Tosto A et al (2005) Effectiveness of early pelvic floor rehabilitation treatment for post-prostatectomy incontinence. Eur Urol 48(5):734–738PubMedCrossRef

40.

Yokoyama T, Nishiguchi J, Watanabe T, Nose H, Nozaki K, Fujita O et al (2004) Comparative study of effects of extracorporeal magnetic innervation versus electrical stimulation for urinary incontinence after radical prostatectomy. Urology 63(2):64–267CrossRef

41.

Parekh AR, Feng MI, Kirages D, Bremner H, Kaswick J, Aboseif S (2003) The role of pelvic floor exercises on post-prostatectomy incontinence. J Urol 170(1):130–133PubMedCrossRef

42.

Wille S, Sobottka A, Heidenreich A, Hofmann R (2003) Pelvic floor exercises, electrical stimulation and biofeedback after radical prostatectomy: results of a prospective randomized trial. J Urol 170(2):490–493PubMedCrossRef

43.

Floratos DL, Sonke GS, Rapidou CA, Alivizatos GJ, Deliveliotis C, Constantinides CA et al (2002) Biofeedback vs. verbal feedback as learning tools for pelvic muscle exercises in the early management of urinary incontinence after radical prostatectomy. BJU Int 89(7):714–719PubMedCrossRef

44.

Van Kampen M, De Weerdt W, Van Poppel H, De Ridder D, Feys H, Baert (2000) Effect of pelvic-floor re-education on duration and degree of incontinence after radical prostatectomy: a randomised controlled trial. Lancet 355(9198):98–102PubMedCrossRef

45.

Bales GT, Gerber GS, Minor TX, Mhoon DA, McFarland JM, Kim HL et al (2000) Effect of preoperative biofeedback/pelvic floor training on continence in men undergoing radical prostatectomy. Urology 56(4):627–630PubMedCrossRef

46.

Mathewson-Chapman M (1997) Pelvic muscle exercise/biofeedback for urinary incontinence after prostatectomy: an education program. J Cancer Educ 12(4):218–223PubMed

47.

Centemero A, Rigatti L, Giraudo D, Lazzeri M, Lughezzani G, Zugna D, Montorsi F, Rigatti P, Guazzoni G (2010) Preoperative pelvic floor muscle exercise for early continence after radical prostatectomy: a randomised controlled study. Eur Urol 57:1039–1044PubMedCrossRef

48.

Moore KN, Griffiths D, Hughton A (1999) Urinary incontinence after radical prostatectomy: a randomized controlled trial comparing pelvic muscle exercises with or without electrical stimulation. BJU Int 83(1):57–65PubMedCrossRef

49.

Hoffmann W, Liedke S, Dombo O, Otto U (2005) Die Elektrostimulation in der Therapie der postoperativen Harninkontinenz- Therapeutischer Nutzen unter Berücksichtigung der Lebensqualität. Urologe 44:33–40PubMedCrossRef

50.

Moore KN, Valiquette L, Chetner MP, Byrniak S, Herbison GP (2008) Return to continence after radical retropubic prostatectomy: a randomized trial of verbal and written instructions versus therapist-directed pelvic floor muscle therapy. Urology 72(6):1280–1286PubMedCrossRef

51.

Franke JJ, Gilbert WB, Grier J, Koch MO, Shyr Y, Smith JA (2000) Early postprostatectomy pelvic floor biofeedback. J Urol 163(3):191–193PubMed

52.

Hwang JH, Chang HJ, Shim YH, Park WH, Park W, Huh SJ et al (2008) Effects of supervised exercise therapy in patients receiving radiotherapy for breast cancer. Yonsei Med J 49(3):443–450PubMedCrossRef

53.

Drouin JS, Young TJ, Beeler J, Byrne K, Birk TJ, Hryniuk WM et al (2006) Random control clinical trial on the effects of aerobic exercise training on erythrocyte levels during radiation treatment for breast cancer. Cancer 107(10):2490–2495PubMedCrossRef

54.

Mock V, Dow KH, Meares CJ, Grimm PM, Dienemann JA, Haisfield-Wolfe ME et al (1997) Effects of exercise on fatigue, physical functioning, and emotional stress during radiation therapy for breast cancer. Oncol Nurs Forum 24(6):991–1000PubMed

55.

Nahon I, Dorey G, Waddington G, Adams R (2006) Systematic review of the treatment of post-prostatectomy incontinence. Urol Nurs 26(6):461–482PubMed

56.

Machold S (2006) Evidenz physiotherapeutischer Behandlung bei Prostatektomie-Inkontinenz. Physioscience 2(3):106–116CrossRef

57.

Kunz R, Khan KS, Kleijnen J, Antes G (2009) Systematische Übersichten und Meta-Analysen– Ein Handbuch für Ärzte in Klinik und Praxis sowie Experten im Gesundheitswesen. Hans Huber, Bern, Schweiz

58.

Baumann FT, Bloch W (2010) Evaluierte Trainingsinterventionen während und nach Tumortherapie – eine Review-Analyse. Deutsche Zeitschrift für Sportmedizin 61(1):6–10

59.

Jüni P, Witschi A, Bloch R, Egger M (1999) The hazards of scoring the quality of clinical trials for meta-analysis. JAMA 282(11):1054–1060PubMedCrossRef

60.

Olivo SA, Macedo L, Gadotti IC, Fuentes TS, Magee DJ (2008) Scales to assess the quality of randomized controlled trials: a systematic review. Phys Ther 88(2):156–175PubMedCrossRef

61.

Galvão DA, Taaffe DR, Spry N, Newton RU (2007) Exercise can prevent and even reverse adverse effects of androgen suppression treatment in men with prostate cancer. Prostate Cancer Prostatic Dis 10(4):340–346PubMedCrossRef

62.

MacDonald R, Fink HA, Huckabay C, Monga M, Wilt TJ (2007) Pelvic floor muscle training to improve urinary incontinence after radical prostatectomy: a systematic review of effectiveness. BJU Int 100(1):76–81PubMedCrossRef

63.

Antonelli J, Freedland SJ, Jones LW (2009) Exercise therapy across the prostate cancer continuum. Prostate Cancer Prostatic Dis 12:110–115PubMedCrossRef

Title: Clinical exercise interventions in prostate cancer patients—a systematic review of randomized controlled trials
Authors: Freerk T. Baumann
Eva M. Zopf
Wilhelm Bloch
Publication date: 01-02-2012
Publisher: Springer-Verlag
Published in: Supportive Care in Cancer / Issue 2/2012
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-011-1271-0

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Introduction

Methods

Results and discussion

Please log in to get access to this content

Other articles of this Issue 2/2012

The Beck Depression Inventory (BDI-II) and a single screening question as screening tools for depressive disorder in Dutch advanced cancer patients

Association of oral mucositis with quality of life and symptom clusters in patients with solid tumors receiving chemotherapy

Baseline depression predicts malnutrition in head and neck cancer patients undergoing radiotherapy

Hispanic adolescents coping with parental cancer

Pneumatosis intestinalis in children with acute lymphoblastic leukemia and acute myeloid leukemia

Weight loss in cancer patients: a plea for a better awareness of the issue

Keynote webinar | Spotlight on antibody–drug conjugates in cancer